| A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks (NCT01832532) | Children's Hospital Medical Center, Cincinnati | 2013-04-01 |
| Fall Risk Reduction in Multiple Sclerosis: Exercise Versus Behavior (NCT01956227) | University of Illinois at Urbana-Champaign | 2013-04-01 |
| Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment (NCT02110459) | Polyphor Ltd. | 2013-04-01 |
| Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab (NCT01845844) | Southeast Retina Center, Georgia | 2013-04-01 |
| Sulforaphane Supplementation in Atopic Asthmatics (NCT01845493) | University of North Carolina, Chapel Hill | 2013-04-01 |
| Study of Metformin Pharmacogenetics in Twins (NCT01869621) | University of Southern Denmark | 2013-04-01 |
| Low Pulse Amplitude Seizure Therapy (LAP-ST Study) (NCT02928159) | Behman Hospital | 2013-04-01 |
| Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM (NCT01816230) | Gamida Cell ltd | 2013-04-01 |
| Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC) (NCT02400788) | Yakult Honsha Co., LTD | 2013-04-01 |
| Occipital Nerve Stimulation in the Treatment of Migraine (NCT01855672) | Ethicon, Inc. | 2013-04-01 |
| Multi-Arm Feasibility Study Evaluating OTX-TP Compared to Timolol in Treatment of Subjects With Open Angle Glaucoma (NCT01845038) | Ocular Therapeutix, Inc. | 2013-04-01 |
| Open Label Pharmacokinetic-Pharmacogenetic Study on Polymorphisms in the Organic Cation Transporter OCT1 (NCT02054299) | University Medical Center Goettingen | 2013-04-01 |
| Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours (NCT01861496) | Allarity Therapeutics | 2013-04-01 |
| Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults (NCT01783977) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-04-01 |
| Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 1015550 Powder for Oral Solution (NCT01835899) | Boehringer Ingelheim | 2013-04-01 |
| QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer (NCT01834235) | Precision Biologics, Inc | 2013-04-01 |
| A Two Way Cross Over Pharmacokinetic Interaction Study Between Raltegravir and Amlodipine in Healthy Volunteers (NCT01841593) | St Stephens Aids Trust | 2013-04-01 |
| Efficacy of Jobelyn™ Consumption on Hemoglobin Levels in a Borderline Anemic Population (NCT01828060) | Natural Immune Systems Inc | 2013-04-01 |
| A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer (NCT01931943) | Qilu Pharmaceutical Co., Ltd. | 2013-04-01 |
| Single Ascending Dose Study of Safety and Tolerability of Sarilumab and Methotrexate in Japanese Patients With Rheumatoid Arthritis (NCT01850680) | Sanofi | 2013-04-01 |
| Brain Dynamics of Oxytocin (NCT01834261) | Stony Brook University | 2013-04-01 |
| Phase1 Study of Gemcitabine HCl Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and Malignant Lymphomas (NCT01800630) | InnoPharmax Inc. | 2013-04-01 |
| Step-up to Quit: Using Low-to-moderate Intensity Exercise for Reducing Smoking Cue Reactivity Among Low-income Smokers (NCT02220465) | Temple University | 2013-04-01 |
| Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC) (NCT01915524) | CureVac | 2013-04-01 |
| Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients (NCT01844973) | Maruho North America Inc. | 2013-04-01 |
| Evaluation of the Biodistribution and Safety of 99mTC-Etarfolatide (EC20) in Normal Volunteers (NCT01748864) | Endocyte | 2013-04-01 |
| Palliative Thoracic Radiotherapy Plus BKM120 (NCT02128724) | University of Oxford | 2013-04-01 |
| The Safety and Tolerability of Secretrol in Patients With Barrett's Esophagus (NCT01905202) | Effexus Pharmaceutical | 2013-04-01 |
| Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (NCT01408160) | Albert Einstein College of Medicine | 2013-04-01 |
| A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma (NCT01969942) | University of Louisville | 2013-04-01 |
| A Phase 1/2, RU-101 Ophthalmic Solution in Patients With Severe Dry Eye (NCT01843894) | R-Tech Ueno, Ltd. | 2013-04-01 |
| Feasibility Study of New MRI Protocol in Assessing Early Blood Brain Barrier Disruption (BBBD)in Related to Delay Brain Edema (NCT01830894) | Sheba Medical Center | 2013-04-01 |
| Safety and Efficacy of SNX-5422 in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Cancers (NCT01848756) | Esanex Inc. | 2013-04-01 |
| A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies (NCT01805375) | Cancer Research UK | 2013-04-01 |
| 99mTc-rhAnnexin V-128: a First In Man Study in Healthy Volunteers (NCT02182609) | Advanced Accelerator Applications | 2013-04-01 |
| Augmentation of Locomotor Adaptation Post-Stroke (NCT02892084) | Medical University of South Carolina | 2013-04-01 |
| An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors (NCT01822756) | Incyte Corporation | 2013-04-01 |
| Analyzing Stump-socket Interface Pressure to Improve Gait in Above-knee Amputee (NCT01848964) | University Hospital, Grenoble | 2013-04-01 |
| Multiple Dose Safety Tolerability, Pharmacokinetics And Midazolam Interaction In Healthy Overweight And Obese Subjects (NCT01807377) | Pfizer | 2013-04-01 |
| Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion (NCT02614937) | Ohr Pharmaceutical Inc. | 2013-04-01 |
| Safety and Tolerability Study of Multiple Doses of PF-06305591 (NCT01776619) | Pfizer | 2013-04-01 |
| Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus (NCT01835730) | PhaseBio Pharmaceuticals Inc. | 2013-04-01 |
| Bioequivalence of Empagliflozin and Metformin Given as a Fixed Dose Combination Compared to Single Tablets (NCT01844531) | Boehringer Ingelheim | 2013-04-01 |
| Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma (NCT01764477) | Prism Pharma Co., Ltd. | 2013-04-01 |
| cMet CAR RNA T Cells Targeting Breast Cancer (NCT01837602) | University of Pennsylvania | 2013-04-01 |
| Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 50 mg (NCT01884857) | IPCA Laboratories Ltd. | 2013-04-01 |
| Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic Cancer (NCT02382263) | PH Research, S.L. | 2013-04-01 |
| A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects (NCT01860625) | Icure Pharmaceutical Inc. | 2013-04-01 |
| Safety and Efficacy of Cryoablation Combined With Radiation Therapy for the Palliation of Painful Bone Metastases (NCT01461252) | Boston Scientific Corporation | 2013-04-01 |
| Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths (NCT01788774) | Rovi Pharmaceuticals Laboratories | 2013-04-01 |
| Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem Cells (NCT01828723) | Antria | 2013-04-01 |
| A Study Comparing Amorphous Calcium Carbonate (ACC) Versus Crystalline Calcium CCS) in Hypoparathyroidism Patients (NCT01815021) | Amorphical Ltd. | 2013-04-01 |
| Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers (NCT01830764) | Dermira, Inc. | 2013-04-01 |
| Safety and Efficacy Study of Umbilical Cord-Derived Mesenchymal Stem Cells for Rheumatoid Arthritis (NCT01547091) | Alliancells Bioscience Corporation Limited | 2013-04-01 |
| Phase 1 Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus (NCT02373215) | Trevi Therapeutics | 2013-04-01 |
| Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis (NCT01582932) | Mayne Pharma International Pty Ltd | 2013-04-01 |
| Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer (NCT01823978) | Bellicum Pharmaceuticals | 2013-04-01 |
| Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd) (NCT01857115) | European Myeloma Network B.V. | 2013-04-01 |
| Buspirone as a Candidate Medication for Methamphetamine Abuse (NCT01843205) | University of Kentucky | 2013-04-01 |
| Effect Of Single-Dose PF-05175157 On Metabolic And Cardiopulmonary Parameters (NCT01819922) | Pfizer | 2013-04-01 |
| A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment (NCT01836185) | Eli Lilly and Company | 2013-04-01 |
| Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn® (NCT01820091) | Acrotech Biopharma Inc. | 2013-04-01 |
| Mindful Yoga Therapy as an Adjunctive Treatment for PTSD Among OEF/OIF Veterans (NCT01521442) | VA Connecticut Healthcare System | 2013-04-01 |
| BR in Patients With CLL With Comorbidities and/or Renal Dysfunction (NCT01832922) | Dartmouth-Hitchcock Medical Center | 2013-04-01 |
| Safety & Immunogenicity of Immunisations With EN41-UGR7C HIV Vaccine (NCT01827397) | PX'Therapeutics | 2013-04-01 |
| Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X (NCT01869933) | OcuCure Therapeutics, Inc. | 2013-04-01 |
| Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation (NCT01841632) | Prof. Dr. Marc-H. Dahlke, Ph. D. | 2013-04-01 |
| CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer (NCT01835041) | Wake Forest University Health Sciences | 2013-04-01 |
| Pilot Study: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Prevention (NCT01780974) | Oregon Health and Science University | 2013-04-01 |
| A Drug Interaction Study of GDC-0032 Co-administered With Rifampin or Itraconazole in Healthy Volunteers (NCT01814709) | Genentech, Inc. | 2013-04-01 |
| EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer (NCT01834170) | University of Tehran | 2013-04-01 |
| Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety (NCT01857596) | S1 Biopharma, Inc. | 2013-04-01 |
| Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma (NCT01800838) | Kevin Cooper MD | 2013-04-01 |
| Treatment CLI Nonrevascularizable Lower Limb With Cell Therapy (NCT01824069) | Instituto de Investigación Hospital Universitario La Paz | 2013-04-01 |
| Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation (NCT01836341) | Memorial Sloan Kettering Cancer Center | 2013-04-01 |
| High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma (NCT01840566) | Memorial Sloan Kettering Cancer Center | 2013-04-01 |
| Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine or Chloroquine/Azithromycin Prophylaxis (NCT01783340) | Radboud University Medical Center | 2013-04-01 |
| A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male Volunteers (NCT01821066) | Pfizer | 2013-04-01 |
| The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions (NCT01878929) | University Hospitals Cleveland Medical Center | 2013-04-01 |
| A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes. (NCT01843127) | Gilead Sciences | 2013-04-01 |
| Bioequivalence Study Between Lamivudine Formulations in the Form of Coated Tablet of 150 mg in Healthy Volunteers (NCT02604004) | Universidade Federal de Pernambuco | 2013-04-01 |
| Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors (NCT01803282) | Gilead Sciences | 2013-03-29 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis (NCT01831427) | Gilead Sciences | 2013-03-28 |
| Autologous Cell Therapy for Treatment of Fecal Incontinence (NCT01600755) | Cook MyoSite | 2013-03-28 |
| Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking Vaccine (NCT01867463) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-03-27 |
| Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water (NCT01246869) | University of Utah | 2013-03-27 |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer (NCT01847326) | University of Chicago | 2013-03-26 |
| Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma (NCT01744171) | Roswell Park Cancer Institute | 2013-03-26 |
| Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC (NCT01757288) | University of Texas Southwestern Medical Center | 2013-03-25 |
| Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis (NCT05488990) | Lipidor AB | 2013-03-25 |
| Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies (NCT01813474) | AstraZeneca | 2013-03-25 |
| Validation of a Physiological Based Pharmacokinetic Model by the Study of Paracetamol Distribution in the Brain Compartments in Brain Injured Patients (NCT03223506) | Poitiers University Hospital | 2013-03-23 |
| Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma (NCT01738594) | Northwestern University | 2013-03-22 |
| A Phase I Dose Escalation Study of CGM097 in Adult Patients With Selected Advanced Solid Tumors (NCT01760525) | Novartis Pharmaceuticals | 2013-03-20 |
| A Clinical Trial of AdNRGM Plus CB1954 in Prostate Cancer (NCT04374240) | University of Birmingham | 2013-03-19 |
| Allogeneic Cord Blood Cells for Adults With Severe Acute Contusion Spinal Cord Injury (NCT04331405) | Sklifosovsky Institute of Emergency Care | 2013-03-18 |
| A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors (NCT01853306) | AbbVie | 2013-03-18 |
| Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled Prucalopride Succinate in Volunteers (NCT01807000) | Shire | 2013-03-18 |
| A Rising Single Dose Study of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics of MK-8892 (MK-8892-001) (NCT01798849) | Merck Sharp & Dohme LLC | 2013-03-15 |
| A Study to Evaluate the Human Tolerance and Pharmacokinetics of LY03003 (NCT04627155) | Luye Pharma Group Ltd. | 2013-03-15 |